| P2093 | author name string | Orlando M Gutiérrez | |
| P2860 | cites work | Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein | Q24309454 |
| | Mutation of the mouse klotho gene leads to a syndrome resembling ageing | Q24328782 |
| | Proximal tubular phosphate reabsorption: molecular mechanisms | Q28140211 |
| | How fibroblast growth factor 23 works | Q28301673 |
| | Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3 | Q28571270 |
| | Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function | Q33560460 |
| | Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin | Q33562017 |
| | Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. | Q33562186 |
| | Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study | Q33617174 |
| | Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosis | Q33672499 |
| | Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? | Q33684149 |
| | Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study | Q33880783 |
| | Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis | Q33932297 |
| | Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease | Q34017373 |
| | Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population | Q34018038 |
| | Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease | Q34025119 |
| | Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease | Q34027316 |
| | FGF23 induces left ventricular hypertrophy | Q34028891 |
| | FGF23 is a novel regulator of intracellular calcium and cardiac contractility in addition to cardiac hypertrophy | Q34035797 |
| | Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule | Q34072230 |
| | Relation of Serum Phosphorus Levels to Ankle Brachial Pressure Index (from the Third National Health and Nutrition Examination Survey) | Q34146157 |
| | Vascular calcification and inorganic phosphate | Q34384685 |
| | Serum phosphorus concentrations in the third National Health and Nutrition Examination Survey (NHANES III). | Q34611536 |
| | Chronic kidney disease progression and outcome according to serum phosphorus in mild-to-moderate kidney dysfunction | Q34751938 |
| | Intestinal phosphate transport. | Q34768129 |
| | Direct effects of phosphate on vascular cell function | Q34910006 |
| | Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease | Q35218230 |
| | FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis | Q35272291 |
| | Dietary intake of phosphorus modulates the circadian rhythm in serum concentration of phosphorus. Implications for the renal production of 1,25-dihydroxyvitamin D | Q35580493 |
| | Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. | Q35953344 |
| | The emerging role of Klotho in clinical nephrology | Q36098355 |
| | Phosphatonins and the regulation of phosphate homeostasis | Q36604351 |
| | Sodium- and phosphorus-based food additives: persistent but surmountable hurdles in the management of nutrition in chronic kidney disease | Q36640677 |
| | The mechanism of phosphorus as a cardiovascular risk factor in CKD | Q36677622 |
| | Dietary phosphorus is associated with greater left ventricular mass | Q36728820 |
| | Fibroblast growth factor 23, Klotho, and disordered mineral metabolism in chronic kidney disease: unraveling the intricate tapestry of events and implications for therapy | Q36791903 |
| | Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake | Q36884529 |
| | Serum phosphorus levels associate with coronary atherosclerosis in young adults | Q37086648 |
| | Association of serum phosphate with vascular and valvular calcification in moderate CKD. | Q37086670 |
| | Serum phosphorus concentrations and arterial stiffness among individuals with normal kidney function to moderate kidney disease in MESA | Q37123180 |
| | Dietary phosphate restriction suppresses phosphaturia but does not prevent FGF23 elevation in a mouse model of chronic kidney disease | Q37136264 |
| | Dietary phosphorus acutely impairs endothelial function | Q37259290 |
| | Relationships between serum and urine phosphorus with all-cause and cardiovascular mortality: the Osteoporotic Fractures in Men (MrOS) Study | Q37274273 |
| | Investigation of gender heterogeneity in the associations of serum phosphorus with incident coronary artery disease and all-cause mortality | Q37288856 |
| | Baseline predictors of renal disease progression in the African American Study of Hypertension and Kidney Disease | Q37322636 |
| | Mineral metabolism and inflammation in chronic kidney disease patients: a cross-sectional study. | Q37378445 |
| | Effects of sevelamer and calcium-based phosphate binders on lipid and inflammatory markers in hemodialysis patients | Q37449096 |
| | A blueprint for randomized trials targeting phosphorus metabolism in chronic kidney disease | Q37552700 |
| | Contributions to total phosphorus intake: all sources considered | Q38070709 |
| | Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. | Q39366376 |
| | FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment | Q39866881 |
| | A novel function of phosphate-mediated intracellular signal transduction pathways | Q40254868 |
| | Effects of short daily versus conventional hemodialysis on left ventricular hypertrophy and inflammatory markers: a prospective, controlled study | Q40403628 |
| | Klotho prevents renal calcium loss. | Q41989687 |
| | Relationship of ankle blood pressures to cardiovascular events in older adults | Q44551701 |
| | Factors influencing the intake and plasma levels of calcium, phosphorus and magnesium in southern Spain. | Q44858305 |
| | High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients | Q44977753 |
| | Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure. | Q45166203 |
| | Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men. | Q45197408 |
| | Serum phosphate levels and mortality risk among people with chronic kidney disease | Q45198981 |
| | Effect of phosphate binders on oxidative stress and inflammation markers in hemodialysis patients. | Q45926631 |
| | High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients. | Q46035991 |
| | Increased inorganic phosphate induces human endothelial cell apoptosis in vitro | Q46667188 |
| | Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men. | Q46680438 |
| | Relation between serum phosphate level and cardiovascular event rate in people with coronary disease | Q46772376 |
| | Phosphorus levels are associated with subclinical atherosclerosis in the general population | Q46841204 |
| | Klotho protein protects against endothelial dysfunction | Q47799420 |
| | Mineral metabolism, mortality, and morbidity in maintenance hemodialysis | Q50144395 |
| | Combined therapy with lanthanum carbonate and calcium carbonate for hyperphosphatemia decreases serum FGF-23 level independently of calcium and PTH (COLC Study) | Q57218844 |
| | Relations of Serum Phosphorus and Calcium Levels to the Incidence of Cardiovascular Disease in the Community | Q57308708 |
| | High-calcium vs high-phosphate intake and small artery tone in advanced experimental renal insufficiency | Q57417577 |
| | Association of Disorders in Mineral Metabolism with Progression of Chronic Kidney Disease | Q57772116 |
| | Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study | Q59575076 |
| | Reduction of Hyperphosphatemia is Related with the Reduction of C-Reactive Protein in Dialysis Patients. Study in Sevelamer-Resistant Dialysis Patients Treated with Chitosan Chewing Gum as Salivary Phosphate Binder | Q62002793 |
| | In vivo klotho gene delivery protects against endothelial dysfunction in multiple risk factor syndrome | Q64380372 |
| | Elevated secretion and action of serum parathyroid hormone in young adults consuming high phosphorus, low calcium diets assembled from common foods | Q69820407 |
| | Endothelial dysfunction in the klotho mouse and downregulation of klotho gene expression in various animal models of vascular and metabolic diseases | Q73988289 |
| | Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women | Q79995263 |
| | High phosphorus intakes acutely and negatively affect Ca and bone metabolism in a dose-dependent manner in healthy young females | Q80152599 |
| | Left ventricular function and calcium phosphate plasma levels in uraemic patients | Q81220224 |
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cardiovascular disease | Q389735 |
| P304 | page(s) | 723-729 | |
| P577 | publication date | 2013-11-06 | |
| P1433 | published in | Advances in Nutrition | Q20821073 |
| P1476 | title | The connection between dietary phosphorus, cardiovascular disease, and mortality: where we stand and what we need to know | |
| P478 | volume | 4 | |